Regulation of Liver Growth and Function

Project: Research project

Project Details

Description

? DESCRIPTION (provided by applicant): There is a fundamental gap in our understanding of how diet and nutrients induce variation in signaling pathways and mechanisms to initiate alterations in translational control of hepatic gene expression that contribute to the pathogenesis of fatty liver disease. Continued existence of this gap represents an important problem because, until it is filled, understanding the etiology of fatty liver disease and developing interventions o prevent or reverse it will remain largely unfulfilled. Our long-term goal is to better understand te translational control of gene expression in the liver. The objective of the project proposed in thi application is to characterize translational control mechanisms and protein expression patterns that undergo acute variation in response to initiating consumption of a diet high in sugar and saturated fat (i.e. a Western diet). Our central hypothesis is that acute variation in protein expression in response to the diet is mediated through mechanisms involving the function of eIF4F and the 43S preinitiation complex. The rationale for the proposed research is that understanding diet-induced acute variation in these mechanisms has the potential to translate into better under-standing the pathogenesis of non-alcoholic fatty liver disease, a condition that affects about one-third of the US population. Guided by strong and in some cases novel preliminary findings, the hypothesis will be tested in the liver of mice following initiation of consumption of a Western diet by pursuing the following three specific aims: 1) Define variation in mTORC1 signaling and protein expression patterns; 2) Characterize expression and covalent modification (i.e. phosphorylation and O-GlcNAcylation) of initiation factors involved in assembly and function of eIF4F; and 3) Assess phosphorylation of the a-subunit of eIF2 as well as phosphorylation and GEF activity of eIF2B. Under the first aim, a novel mechanism suggested by our preliminary data for the Rheb- and Rag-mediated inputs to mTORC1 will be explored to develop an understanding of how the Western diet affects this hormone and nutrient sensing pathway. In addition, a recently developed technology that is now established in our laboratory will be used to identify variation in protein expression patterns. Under the second aim, we will extend our recent discovery of hyperglycemia-mediated O-GlcNAcylation of 4E-BP1 and eIF4G to studies on its role in regulating assembly and function of the eIF4F complex. Under the third aim, we will rely on our extensive experience in studies on assembly of the 43S preinitiation complex to gain an understanding of the relative roles of PERK and/or PKR-dependent phosphorylation of eIF2a and a corresponding reduction in eIF2B activity in protein expression from mRNAs with upstream open reading frames. The proposed research is significant because it is expected to advance and expand our understanding of how diet and nutrients can mediate variation in the patterns of gene expression in the liver leading to maladapted metabolism. Ultimately, such knowledge has the potential to inform development of both dietary counseling and pharmacologic intervention to prevent or reverse fatty liver disease.
StatusFinished
Effective start/end date2/1/958/31/20

Funding

  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $408,981.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $428,328.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $428,272.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $442,980.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $432,352.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $403,728.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $411,095.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $412,173.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $403,729.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $408,981.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $8,990.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $403,728.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $425,805.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $451,487.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $444,254.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $408,981.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $408,981.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $431,842.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $442,685.00
  • NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES: $389,597.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.